U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.1694G>T (p.Gly565Val) AND Hypercholesterolemia, familial, 1

Germline classification:
Pathogenic/Likely pathogenic (8 submissions)
Last evaluated:
Nov 15, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000003874.15

Allele description [Variation Report for NM_000527.5(LDLR):c.1694G>T (p.Gly565Val)]

NM_000527.5(LDLR):c.1694G>T (p.Gly565Val)

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.1694G>T (p.Gly565Val)
Other names:
G544V; FH Naples; FH Naples-2
HGVS:
  • NC_000019.10:g.11116201G>T
  • NG_009060.1:g.31821G>T
  • NM_000527.5:c.1694G>TMANE SELECT
  • NM_001195798.2:c.1694G>T
  • NM_001195799.2:c.1571G>T
  • NM_001195800.2:c.1190G>T
  • NM_001195803.2:c.1313G>T
  • NP_000518.1:p.Gly565Val
  • NP_000518.1:p.Gly565Val
  • NP_001182727.1:p.Gly565Val
  • NP_001182728.1:p.Gly524Val
  • NP_001182729.1:p.Gly397Val
  • NP_001182732.1:p.Gly438Val
  • LRG_274t1:c.1694G>T
  • LRG_274:g.31821G>T
  • LRG_274p1:p.Gly565Val
  • NC_000019.9:g.11226877G>T
  • NM_000527.4:c.1694G>T
  • P01130:p.Gly565Val
  • c.1694G>T
  • p.(Gly565Val)
Protein change:
G397V; GLY544VAL
Links:
LDLR-LOVD, British Heart Foundation: LDLR_000424; UniProtKB: P01130#VAR_005401; OMIM: 606945.0014; dbSNP: rs28942082
Molecular consequence:
  • NM_000527.5:c.1694G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195798.2:c.1694G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195799.2:c.1571G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195800.2:c.1190G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195803.2:c.1313G>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
4

Condition(s)

Name:
Hypercholesterolemia, familial, 1
Synonyms:
LDL RECEPTOR DISORDER; Hyperlipoproteinemia Type IIa; HYPER-LOW-DENSITY-LIPOPROTEINEMIA; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007750; MedGen: C0745103; Orphanet: 391665; OMIM: 143890

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000024039OMIM
no assertion criteria provided
Pathogenic
(Sep 15, 1988)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV000295584LDLR-LOVD, British Heart Foundation
criteria provided, single submitter

(ACGS Guidelines, 2013)
Likely pathogenic
(Mar 25, 2016)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

Citation Link,

SCV000503387Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies, APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Dec 16, 2016)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000583865U4M - Lille University & CHRU Lille, Université de Lille - CHRU de Lille
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Mar 30, 2017)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000599379Cardiovascular Research Group, Instituto Nacional de Saude Doutor Ricardo Jorge
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Mar 1, 2016)
germline, not applicablecuration, literature only

PubMed (2)
[See all records that cite these PMIDs]

SCV000606487Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, Academisch Medisch Centrum
no assertion criteria provided
Pathogenicgermlineresearch

SCV001653646Laboratory of molecular diagnosis of dyslipidemias, Università egli studi di Napoli Federico II
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(May 24, 2021)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

SCV004825832All of Us Research Program, National Institutes of Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely Pathogenic
(Nov 15, 2023)
germlineclinical testing

PubMed (15)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providednot applicablenot applicablenot providednot providednot providednot providednot providedliterature only
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineyes144not provided2602not providedclinical testing, literature only
not providedgermlineunknown1not providednot provided108544not providedclinical testing, research, curation
Caucasiangermlineyes2not providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular genetics of the LDL receptor gene in familial hypercholesterolemia.

Hobbs HH, Brown MS, Goldstein JL.

Hum Mutat. 1992;1(6):445-66. Review.

PubMed [citation]
PMID:
1301956
See all PubMed Citations (15)

Details of each submission

From OMIM, SCV000024039.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

Esser and Russell (1988) found a GGC-to-GTC mutation as the basis of this variant.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From LDLR-LOVD, British Heart Foundation, SCV000295584.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedliterature only PubMed (2)
2not provided1not providednot providedliterature only PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided
2germlineyes1not providednot provided1not providednot providednot provided

From Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies, APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix, SCV000503387.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided6not providednot providedclinical testing PubMed (1)

Description

subjects mutated among 2600 FH index cases screened = 6 , family members = 2 with co-segregation / Functional test, FH-Naples-2, 2% LDLR Activity, Other mutations at same codon / Software predictions: Damaging

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes2600not providednot provided6not providednot providednot provided

From U4M - Lille University & CHRU Lille, Université de Lille - CHRU de Lille, SCV000583865.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided6not providednot providedclinical testing PubMed (1)

Description

Dutch Lipid Clinic Scoring : Definite FH

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided6not provided4not provided

From Cardiovascular Research Group, Instituto Nacional de Saude Doutor Ricardo Jorge, SCV000599379.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (2)
2not providednot providednot providednot providedliterature only PubMed (2)

Description

"Assay Description:Hmz patients' fibroblasts, 125I-LDL assays"
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided
2not applicablenot applicablenot providednot providednot providednot providednot providednot providednot provided

From Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, Academisch Medisch Centrum, SCV000606487.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearchnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Laboratory of molecular diagnosis of dyslipidemias, Università egli studi di Napoli Federico II, SCV001653646.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1Caucasian2not providednot providedclinical testing PubMed (4)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided2not providednot providednot provided

From All of Us Research Program, National Institutes of Health, SCV004825832.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (15)

Description

The c.1694G>T (p.Gly565Val) variant in LDLR gene, that encodes for low density lipoprotein receptor, has been identified in at least five individuals who fulfill the clinical criteria of Familial Hypercholesterolemia (FH) (PMID:12436241, 23375686, 32770674, 28161202). This variant has also been reported in homozygous/compound heterozygous (with p.Trp4*) status in individuals with severe FH (PMID: 27784735, 6299582). This variant has also been detected in hypercholesterolemia cohorts and cohorts referred for FH testing (PMID: 34037665, 34297352). Experimental studies on transfected CHO cells demonstrated that this variant caused complete retention of protein on the endoplasmic reticulum, severely affected LDLR surface expression, and no LDL particle internalization (PMID: 16740646, 16257961). In addition, studies on homozygous mutant cells showed LDLR activity of <2% compared to wild type (PMID: 1301956, 2901412, 6299582). In-silico computational prediction tools suggest that this variant may have deleterious effect on the protein function (REVEL score: 0.971). This variant is found to be absent in the general population database, gnomAD and interpreted as likely pathogenic/pathogenic by several submitters (10) in the ClinVar database (ClinVar ID: 3688). Other amino acid substitutions at the same codon (p.Gly565Arg, p.Gly565Asp, p.Gly565Ala) have been reported in individuals with FH (PMID: 33994402, 27784735, 11313767) and classified as likely pathogenic by ClinVar submitters (ClinVar ID: 1778186, 375819, 226366). Therefore, the c.1694G>T (p.Gly565Val) variant in LDLR gene is classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown108544not providednot provided1not providednot providednot provided

Last Updated: Apr 12, 2026

Modify your search Search (all fields optional) Clear all
Advanced Search